Protein microarrays for validation of affinity binders

Is specificity an important issue regarding affinity reagents? What about the validation of affinity reagents today, is it good enough? This depends on the application and the producer of the reagent. Validation should be the most important marketing argument that can be found.Today there is a conti...

Full description

Bibliographic Details
Main Author: Sundberg, Mårten
Format: Others
Language:English
Published: KTH, Proteomik 2011
Subjects:
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-48256
http://nbn-resolving.de/urn:isbn:978-91-7501-149-3
id ndltd-UPSALLA1-oai-DiVA.org-kth-48256
record_format oai_dc
spelling ndltd-UPSALLA1-oai-DiVA.org-kth-482562013-01-08T13:10:50ZProtein microarrays for validation of affinity bindersengSundberg, MårtenKTH, ProteomikStockholm : KTH Royal Institute of Technology2011MicroarrayproteinantibodyantigenaffinityvalidationIs specificity an important issue regarding affinity reagents? What about the validation of affinity reagents today, is it good enough? This depends on the application and the producer of the reagent. Validation should be the most important marketing argument that can be found.Today there is a continuous growth of both the number of affinity reagents that are produced and the different types of affinity reagents that are developed. In proteomics they become more and more important in exploring the human proteome. Therefore, validated affinity reagents should be on top of every proteomic researcher’s list. How should this be accomplished?Better international agreements on how affinity reagents should be tested to be regarded as functional reagents are needed. One of the most important issues is the specificity of the affinity reagent. An international standard for which specific validation that is needed for different kinds of applications would be very useful.In this thesis, it is shown that the protein microarray platform that was established within the HPA project at KTH is a very good tool to determine the specificity of different affinity binders.In the first study, the production of mono-specific antibodies for tissue profiling in the Human Protein Atlas (HPA) project is presented. The section describing the use of protein microarrays for validation of the antibodies is relevant for this thesis. The implementation of protein microarrays in the HPA workflow was an important addition, because a deeper insight of the specificity of all the antibodies produced were now available.In a second study, bead based arrays were compared to planar protein microarrays used in the HPA project. In this study, 100 different bead identities were coupled with 100 different antigens and mixed together to generate an array. The correlation between the two types of assays was very high and the conclusion was that the methods can be used as backup to each other.A third study was a part of an international initiative to produce renewable affinity binders against proteins containing SH2 domain. Here, the HPA protein microarrays were modified to analyze different types of reagents produced at six laboratories around the world. Monoclonal antibodies, single chain fragment and fibronectin scaffolds were tested as well as mono-specific antibodies. It was shown to be possible to adapt protein microarrays used in the HPA project to validate other kinds of affinity reagents. QC 20111117Development and applications of protein microarraysThe Swedish Human Proteome Resource (HPR) programLicentiate thesis, comprehensive summaryinfo:eu-repo/semantics/masterThesistexthttp://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-48256urn:isbn:978-91-7501-149-3Trita-BIO-Report, 1654-2312 ; 2011:23application/pdfinfo:eu-repo/semantics/openAccess
collection NDLTD
language English
format Others
sources NDLTD
topic Microarray
protein
antibody
antigen
affinity
validation
spellingShingle Microarray
protein
antibody
antigen
affinity
validation
Sundberg, Mårten
Protein microarrays for validation of affinity binders
description Is specificity an important issue regarding affinity reagents? What about the validation of affinity reagents today, is it good enough? This depends on the application and the producer of the reagent. Validation should be the most important marketing argument that can be found.Today there is a continuous growth of both the number of affinity reagents that are produced and the different types of affinity reagents that are developed. In proteomics they become more and more important in exploring the human proteome. Therefore, validated affinity reagents should be on top of every proteomic researcher’s list. How should this be accomplished?Better international agreements on how affinity reagents should be tested to be regarded as functional reagents are needed. One of the most important issues is the specificity of the affinity reagent. An international standard for which specific validation that is needed for different kinds of applications would be very useful.In this thesis, it is shown that the protein microarray platform that was established within the HPA project at KTH is a very good tool to determine the specificity of different affinity binders.In the first study, the production of mono-specific antibodies for tissue profiling in the Human Protein Atlas (HPA) project is presented. The section describing the use of protein microarrays for validation of the antibodies is relevant for this thesis. The implementation of protein microarrays in the HPA workflow was an important addition, because a deeper insight of the specificity of all the antibodies produced were now available.In a second study, bead based arrays were compared to planar protein microarrays used in the HPA project. In this study, 100 different bead identities were coupled with 100 different antigens and mixed together to generate an array. The correlation between the two types of assays was very high and the conclusion was that the methods can be used as backup to each other.A third study was a part of an international initiative to produce renewable affinity binders against proteins containing SH2 domain. Here, the HPA protein microarrays were modified to analyze different types of reagents produced at six laboratories around the world. Monoclonal antibodies, single chain fragment and fibronectin scaffolds were tested as well as mono-specific antibodies. It was shown to be possible to adapt protein microarrays used in the HPA project to validate other kinds of affinity reagents. === QC 20111117 === Development and applications of protein microarrays === The Swedish Human Proteome Resource (HPR) program
author Sundberg, Mårten
author_facet Sundberg, Mårten
author_sort Sundberg, Mårten
title Protein microarrays for validation of affinity binders
title_short Protein microarrays for validation of affinity binders
title_full Protein microarrays for validation of affinity binders
title_fullStr Protein microarrays for validation of affinity binders
title_full_unstemmed Protein microarrays for validation of affinity binders
title_sort protein microarrays for validation of affinity binders
publisher KTH, Proteomik
publishDate 2011
url http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-48256
http://nbn-resolving.de/urn:isbn:978-91-7501-149-3
work_keys_str_mv AT sundbergmarten proteinmicroarraysforvalidationofaffinitybinders
_version_ 1716511114546642944